Hong Kong approves celebrity weight-loss drug, but experts say it’s not just to look good
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...
Yahoo15h
A stronger Ozempic, a Boeing supplier in trouble, and a simpler Starbucks: Business news roundup
Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday. The ...
Ozempic’s maker wants the US government to ban cheaper versions of the high-priced $969 injection weight-loss drug – claims the formula is ‘too complex’ to cop…
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
Yahoo19h
What Trump's win means, stronger Ozempic, and cars to avoid: The week's most popular stories
Read More Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday ...
verywellhealth1d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
BioPharma Dive1d
What RFK Jr.’s influence on Trump could mean for pharma
Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...
Becker's Hospital Review1d
3 Ozempic updates: Competition, warnings and potential uses
Since Eli Lilly's Mounjaro and Novo Nordisk's Wegovy and Ozempic fell into shortage in late 2022, compounding pharmacies have been manufacturing their respective generics, tirzepatide and semaglutide.